| Adverse food–drug interactions A de Boer, F van Hunsel, A Bast Regulatory Toxicology and Pharmacology 73 (3), 859-865, 2015 | 55 | 2015 |
| International legislation on nutrition and health claims A de Boer, A Bast Food Policy 55, 61-70, 2015 | 55 | 2015 |
| Demanding safe foods–Safety testing under the novel food regulation (2015/2283) A de Boer, A Bast Trends in Food Science & Technology, 2018 | 45 | 2018 |
| Implementation of the nutrition and health claim regulation–The case of antioxidants A de Boer, E Vos, A Bast Regulatory Toxicology and Pharmacology 68 (3), 475-487, 2014 | 41 | 2014 |
| Clarifying the health claim assessment procedure of EFSA will benefit functional food innovation KGM Lenssen, A Bast, A de Boer Journal of Functional Foods 47, 386-396, 2018 | 37 | 2018 |
| The framing of innovation among European research funding actors: Assessing the potential for ‘responsible research and innovation’in the food and health domain SS Khan, L Timotijevic, R Newton, D Coutinho, JL Llerena, S Ortega, ... Food Policy 62, 78-87, 2016 | 35 | 2016 |
| Active ingredients leading in health claims on functional foods A de Boer, MJE Urlings, A Bast Journal of Functional Foods 20, 587-593, 2016 | 32 | 2016 |
| The effect of dietary components on inflammatory lung diseases – a literature review A de Boer, WRPH van de Worp, GJ Hageman, A Bast International Journal of Food Sciences and Nutrition, 2017 | 17 | 2017 |
| Stakeholders' perception of the nutrition and health claim regulation A de Boer, A Bast International journal of food sciences and nutrition 66 (3), 321-328, 2015 | 17 | 2015 |
| Valorized Food Processing By-Products in the EU: Finding the Balance between Safety, Nutrition, and Sustainability M Rao, A Bast, A de Boer Sustainability 13 (8), 4428, 2021 | 13 | 2021 |
| EU food legislation impacts innovation in the area of plant-based dairy alternatives A Leialohilani, A de Boer Trends in Food Science & Technology 104, 262-267, 2020 | 13 | 2020 |
| Scientific assessments in European food law: Making it future-proof A de Boer Regulatory Toxicology and Pharmacology 108, 104437, 2019 | 13 | 2019 |
| International Perspectives on Substantiating the Efficacy of Herbal Dietary Supplements and Herbal Medicines Through Evidence on Traditional Use K Lenssen, A Bast, A de Boer Comprehensive Reviews in Food Science and Food Safety 18 (4), 910-922, 2019 | 11 | 2019 |
| Dietary supplement intake during pregnancy; better safe than sorry? A de Boer, A Bast, R Godschalk Regulatory Toxicology and Pharmacology 95, 442-447, 2018 | 11 | 2018 |
| Immunomodulating Effects of Fungal Beta-Glucans: From Traditional Use to Medicine HP van Steenwijk, A Bast, A de Boer Nutrients 13 (4), 1333, 2021 | 10 | 2021 |
| A call for action on the development and implementation of new methodologies for safety assessment of chemical-based products in the EU–A short communication DJ Knight, H Deluyker, Q Chaudhry, JM Vidal, A de Boer Regulatory Toxicology and Pharmacology 119, 104837, 2021 | 10 | 2021 |
| Fifteen Years of Regulating Nutrition and Health Claims in Europe: The Past, the Present and the Future A de Boer Nutrients 13 (5), 1725, 2021 | 9 | 2021 |
| The Role of Circulating Lycopene in Low-Grade Chronic Inflammation: A Systematic Review of the Literature HP van Steenwijk, A Bast, A de Boer Molecules 25 (19), 4378, 2020 | 9 | 2020 |
| The barriers and drivers of a safe market introduction of cultured meat: A qualitative study L Ketelings, S Kremers, A de Boer Food Control 130, 108299, 2021 | 7 | 2021 |
| Conveying information through food packaging: A literature review comparing legislation with consumer perception HNJ Schifferstein, A de Boer, M Lemke Journal of Functional Foods 86, 104734, 2021 | 6 | 2021 |
A. BastProfessor of ToxicologyGeverifieerd e-mailadres voor maastrichtuniversity.nl
